In a recent commentary (1), Dr. Lea Steele provided a valuable survey of evaluations of the health of Persian Gulf War veterans. Investigating whether veterans of the Gulf War exhibit adverse health effects from their Gulf service, she questioned the use of exploratory factor analysis (EFA) (2-7) and recommended an alternative approach for investigation. Specifically, Steele stated that 1) "epidemiologic methods" (1, p. 408) are preferable to EFA in determining the presence or absence of a unique syndrome and 2) comparisons among veterans deployed to the Gulf theater and veterans deployed elsewhere should be the most informative. She defined epidemiologic methods as "generating a description of the illness and then delineating its distribution in a given population according to characteristics of person, place, and time" (1, p. 408), as in her study of Kansas-based Gulf War-era veterans (8) . In that study, she defined symptom groups as reliable if they had a Cronbach's α of 0.7 or greater and an item-scale correlation of at least 0.5 (8, p. 993). Steele then defined illness as having "moderate or multiple symptoms in at least three of the six defined [symptom] groups" (8, p. 995) and found a prevalence of approximately 34 percent. She preferred this "epidemiologic" approach because, in her use of EFA, "The cooccurrence of symptoms in different categories… varied in veteran subgroups" (8, p. 993).
We do not understand Steele's preference for her "epidemiologic" method over EFA, and she does not justify it empirically. First, EFA is an objective, empirical approach, while Steele's "epidemiologic" method depends on the investigator's specification of appropriate categories of symptoms, according to unspecified criteria. Second, because Steele's symptom groups are apparently mutually exclusive, her approach will not identify the co-occurrence of symptoms from different symptom groups. For example, hypothetically, nausea symptoms could result from an underlying gastrointestinal disorder in some subjects and could be one of a constellation of responses to a chemical agent in others. In the first case, it might be grouped with other gastrointestinal symptoms, while in the latter it might be grouped with neurologic or musculoskeletal symptoms. Steele's method would assign it to only one group, while in EFA the symptom could contribute to more than one factor. Third, Steele rejected EFA because results differed among groups of veterans by deployment status and gender. When such heterogeneity is identified, it is prudent to separately analyze homogeneous groups rather than pool the data or change the methodology.
To assess the robustness of EFA, we applied six different EFA implementations to two data sets (3, 7) and found that results differed only in small ways (9) and were similar to Steele's. All methods provided useful and similar descriptions in this instance, which is not surprising given the relative homogeneity of the subjects (Gulf War veterans).
We defined illness by conducting a two-group k-means cluster analysis on our four factors and found a prevalence similar to Steele's-approximately 38 percent (7). We obtained similar results when we applied the same method directly to all 48 symptoms (table 1) , with nearly 95 percent of subjects identically classified and a kappa value of 0.9. This suggests that EFA, while useful descriptively, was not necessary to define illness.
In summary, Steele rejects EFA in preference for her own methods, which are largely based on investigator judgment. While in this case her results correspond closely to those of others, we prefer EFA because it is an objective approach, it is replicable across investigators, and it allows symptom cooccurrence in multiple factors. We agree with Steele that the most informative analyses may compare veterans who differ by deployment status, deployment location, or other factors, and we urge that collection and validation of data on specific exposures and troop locations be made a priority in future conflicts. 
THE AUTHOR REPLIES
I thank Dr. Wartenberg and his colleagues for their comments (1). I appreciate their interest, but the concerns they raise dispute recommendations that were neither made nor implied in my commentary (2) . Specifically, I did not advocate the use of undefined "epidemiologic methods" in lieu of exploratory factor analysis (EFA) to identify a unique syndrome in Gulf War veterans, nor did I suggest comparisons among Gulf War veterans and other veterans for that purpose.
I did comment that, since wartime exposure data are, for the most part, unavailable for the Persian Gulf conflict, epidemiologic methods traditionally used in the absence of individual exposure data could be useful in generating etiologic hypotheses regarding the unexplained illnesses reported by Gulf War veterans. Differences in illness prevalence and profiles associated with Gulf veteran subgroups defined by, for example, place and time of deployment have the potential to identify associations between illness and experiences in theater. This suggested use of traditional epidemiologic methods was separate from, and unrelated to, observations made regarding the use of EFA.
My comments questioning the use of EFA related only to its suitability for determining whether there is or is not a unique "Gulf War syndrome." Wartenberg et al. appear to have mistaken that point for a broader one regarding the use of EFA in general. The distinction between the use of EFA for statistically defining symptom domains and its use to address the question of the presence/absence of a unique "Gulf War syndrome" is not a minor one.
In a growing number of studies (3-9), first-order factors obtained from general lists of symptoms endorsed by heterogeneous groups of Gulf veterans have been found to be similar to symptom factors observed in comparison veteran populations. Does this general similarity in symptom factors mean that there is no "Gulf War syndrome"? The answer is, it doesn't really address the issue. EFA identifies latent constructs that underlie groups of correlated variables. In factor analyses of symptoms, these constructs tend to represent symptom domains associated with difficulties in particular organs or systems. Neurologic difficulties, for example, are often represented by factors that include symptoms such as difficulty concentrating, memory problems, and mood changes-regardless of the etiology or pathophysiology of the problems being expressed. Respiratory conditions often manifest symptoms such as coughing, wheezing, and shortness of breath, which are highly correlated in a population, independently of the diversity of conditions giving rise to those symptoms. Thus, even if subgroups of Gulf veterans experienced, for example, unique combinations of neurotoxic and respiratory insults, the symptoms and first-order factors expressed would probably be similar to those of populations that included persons experiencing other types of neurologic and respiratory difficulties.
While it is interesting that one group of investigators has identified a unique symptom factor among a minority of symptomatic Gulf veterans (8) , the absence of unique firstorder factors in other studies indicates only that symptoms associated with dysfunction in specific organs or systems tend to be correlated in similar ways in different populations, regardless of the specific diseases in those populations.
A more straightforward observation relates to familiar medical conditions found in any population group, including veterans. When symptoms from these populations are subjected to EFA, "unique" symptom factors are not generally identified for common chronic conditions such as diabetes or hypothyroidism. It is unclear why investigators expect that putative "new" conditions associated with Gulf War service should emerge when comparing the results of EFA between Gulf veterans and other populations.
